Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Burning Rock Biotech Ltd ADR (BNR)

Burning Rock Biotech Ltd ADR (BNR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 250,159
  • Shares Outstanding, K 105,109
  • Annual Sales, $ 79,690 K
  • Annual Income, $ -125,020 K
  • 60-Month Beta -0.19
  • Price/Sales 3.20
  • Price/Cash Flow N/A
  • Price/Book 0.98
Trade BNR with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.19
  • Number of Estimates 1
  • High Estimate -0.19
  • Low Estimate -0.19
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +36.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.74 +36.78%
on 06/13/22
2.71 -12.18%
on 05/25/22
-0.28 (-10.53%)
since 05/24/22
3-Month
1.74 +36.78%
on 06/13/22
11.27 -78.88%
on 04/04/22
-7.26 (-75.31%)
since 03/24/22
52-Week
1.74 +36.78%
on 06/13/22
30.50 -92.20%
on 06/29/21
-26.60 (-91.79%)
since 06/24/21

Most Recent Stories

More News
Burning Rock Announces Changes to Board Composition

GUANGZHOU, China, June 24, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the...

BNR : 2.38 (-2.06%)
Burning Rock Announces US$10 Million Share Repurchase Program

GUANGZHOU, China, June 21, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the...

BNR : 2.38 (-2.06%)
Burning Rock Announces Plan to Pursue An Alternative Listing

GUANGZHOU, China, June 21, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the...

BNR : 2.38 (-2.06%)
Burning Rock Biotech Limited (BNR) Q1 2022 Earnings Call Transcript

BNR earnings call for the period ending March 31, 2022.

BNR : 2.38 (-2.06%)
Burning Rock Reports First Quarter 2022 Financial Results

GUANGZHOU, China, May 31, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the...

BNR : 2.38 (-2.06%)
Burning Rock Schedules First Quarter of 2022 Earnings Release on May 31, 2022

GUANGZHOU, China, May 16, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the...

BNR : 2.38 (-2.06%)
Riot Blockchain, Inc. (RIOT) Surpasses Q1 Earnings Estimates

Riot Blockchain, Inc. (RIOT) delivered earnings and revenue surprises of 163.64% and 3.03%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

RIOT : 5.19 (+5.06%)
BNR : 2.38 (-2.06%)
Opendoor Technologies Inc. (OPEN) Surpasses Q1 Earnings and Revenue Estimates

Opendoor Technologies Inc. (OPEN) delivered earnings and revenue surprises of 215.38% and 21.75%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?...

OPEN : 5.66 (+5.20%)
BNR : 2.38 (-2.06%)
Oversold Conditions For Burning Rock Biotech (BNR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

BNR : 2.38 (-2.06%)
Cathie Wood Can't Get Enough of These 2 Biotech Stocks

The CEO of Ark Invest hasn't given up on these risky biotech stocks.

ADPT : 8.75 (+0.57%)
BNR : 2.38 (-2.06%)
ARKG : 34.62 (+2.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Burning Rock Biotech Limited focuses on the application of next generation sequencing technology in the field of precision oncology. Its business consists of NGS-based therapy selection testing for late-stage cancer patients as well as NGS-based cancer early detection. Burning Rock Biotech Limited is...

See More

Key Turning Points

3rd Resistance Point 3.00
2nd Resistance Point 2.84
1st Resistance Point 2.61
Last Price 2.38
1st Support Level 2.22
2nd Support Level 2.06
3rd Support Level 1.83

See More

52-Week High 30.50
Fibonacci 61.8% 19.51
Fibonacci 50% 16.12
Fibonacci 38.2% 12.73
Last Price 2.38
52-Week Low 1.74

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar